Childhood cancer research gets $30 million from feds

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 9
Volume 17
Issue 9

President George W. Bush approved a bill that devotes $30 million annually over 5 years to fund pediatric cancer research.

President George W. Bush approved a bill that devotes $30 million annually over 5 years to fund pediatric cancer research. The Caroline Pryce Walker Conquer Childhood Cancer Act was introduced by Sen. Jack Reed (D-RI) and Sen. Norm Coleman (R-MN) and was passed unanimously in the summer by the House of Representatives and the U.S. Senate. The legislation was named in memory of Caroline Pryce Walker, daughter of Congresswoman Deborah Pryce (R-OH), who died of neuroblastoma in 1999 at age 9.

 


The new law will support funding for collaborative pediatric cancer clinical trials research and to create a population-based national childhood cancer database. Public education campaigns will also be launched to raise awareness about ongoing research in pediatric cancer, according to the CureSearch National Childhood Cancer Foundation. It has yet to be determined which government agency will administer the grant money, a CureSearch spokesperson told ONI.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.